Schroder Investment Management Group
CVAC

Schroder Investment Management Group’s CureVac CVAC Stock Holding History

Schroder Investment Management Group’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,035
Closed -$139K – 1280
2022
Q2 		$139K Sell
10,035
-70,863
-88% -$1.17M ﹤0.01% 1282
2022
Q1 		$1.56M Buy
80,898
+39,692
+96% +$793K ﹤0.01% 1056
2021
Q4 		$1.41M Buy
+41,206
New +$1.66M ﹤0.01% 985

Other funds holding CVAC

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schroder Investment Management Group's CVAC Position: Q3 2022 in Review

Schroder Investment Management Group sold out of CureVac (CVAC) in Q3 2022, closing a stake of 10,035 shares — an estimated $139K sold.

Schroder Investment Management Group first reported a position in CVAC in Q4 2021 and held it in 3 quarters. The position peaked at $1.56M in Q1 2022. 83 funds tracked by Wall St. Rank hold CVAC as of Q3 2022.

  • Schroder Investment Management Group reported no remaining CureVac position as of Q3 2022 after selling out during the quarter.
  • Schroder Investment Management Group sold 10,035 CureVac shares in Q3 2022, an estimated $139K.
  • Schroder Investment Management Group first reported a position in CureVac in Q4 2021 and held it in 3 quarters.
  • Schroder Investment Management Group's CureVac position peaked at $1.56M in Q1 2022.
  • 83 funds tracked by Wall St. Rank held CureVac as of Q3 2022.

Based on Schroder Investment Management Group's 13F filing for Q3 2022, filed 14 Nov 2022.